Rank | Studies sponsored by China | Global studies | Global MRCTs | |||
Country/region | Number | Country/region | Number | Country/region | Number | |
1 | Mainland China | 32 369 | USA | 128 857 | USA | 22 563 |
2 | USA | 125 | Japan | 42 247 | Germany | 19 972 |
3 | Australia | 60 | Germany | 37 886 | UK | 15 672 |
4 | Germany | 35 | Mainland China | 36 657 | Spain | 14 853 |
5 | Taiwan, China | 30 | UK | 35 963 | France | 13 915 |
6 | Spain | 28 | France | 29 649 | Italy | 13 829 |
7 | Italy | 26 | Canada | 25 348 | Canada | 13 573 |
8 | France | 24 | Netherlands | 23 682 | Belgium | 10 691 |
9 | Japan | 24 | Australia | 22 263 | Poland | 9740 |
10 | UK | 21 | Spain | 21 884 | Netherlands | 9480 |
… | … | … | … | … | ||
40 | … | … | Mainland China | 2422 | ||
… | … | … | … | … | … | … |
Data note: There were 1932 registered studies sponsored by China with absent recruitment countries/regions data, and the recruitment country/region was assigned to China after manual verification. Another 28 067 registration entries with absent recruitment countries/regions data were excluded from the analysis because the missing recruitment countries/regions could not be determined manually. In addition, 407 registration entries on JapanPrimary Registries Network only specified the continents of recruitment. The number of recruitment continents was used to represent the number of recruitment countries or regions in these entries.
MRCTs, multiregional clinical trials.